Patients, most of them elderly, are lying on stretchers in hallways and taking oxygen while sitting in wheelchairs as COVID-19 surges in China's capital Beijing.
The Chuiyangliu hospital in the city's east was packed with newly arrived patients on Thursday. By midmorning beds had run out, even as ambulances continued to bring those in need.
Hard-pressed nurses and doctors rushed to take information and triage the most urgent cases.
The surge in severely ill people needing hospital care follows China abandonment of its most severe pandemic restrictions last month after nearly three years of lockdowns, travels bans and school closures that weighed heavily on the economy and prompted street protests not seen since the late 1980s.
It also comes as the the European Union on Wednesday strongly encouraged its member states to impose pre-departure COVID-19 testing of passengers from China.
Over the past week, EU nations have reacted with a variety of restrictions toward travelers from China, disregarding an earlier commitment to act in unity.
Italy where the pandemic first exacted a heavy toll in Europe in early 2020 was the first EU member to require coronavirus tests for airline passengers coming from China, but France and Spain quickly followed with their own measures. That followed the imposition by the U.S. of a requirement that all passengers from China show a negative test result obtained in the previous 48 hours before departure.
China has warned of countermeasures if such policies were to be imposed across the bloc.
Still, World Health Organisation head Tedros Adhanom Ghebreyesus said Wednesday he was concerned about the lack of outbreak data from the Chinese government.
China has sought to get more of its elderly population vaccinated, but those efforts have been hampered by past scandals involving fake medications and previous warnings about adverse reactions to the vaccines among older people.
China's domestically developed vaccines are also considered less effective than the mRNA jabs used elsewhere.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app